Surrozen Inc

XNAS:SRZN   9:52:44 AM EDT
20.74
-0.01 (-0.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)240.80M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.47 Million
Adjusted EPS-$1.29
See more estimates
10-Day MA$26.21
50-Day MA$28.84
200-Day MA$20.38
See more pivots

Surrozen Inc Stock, XNAS:SRZN

171 Oyster Point Boulevard, Suite 400, South San Francisco, California 94080
United States of America
Phone: +1.650.489.9000
Number of Employees: 42

Description

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.